Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Generic Lid-Care wipes
110801000AAABAB
|
Generic compound preparation BNF 1108010 | Other eye tear/lubricant/astringent preparations | Eye | 1 |
|
Genticin 0.3% eye/ear drops
1103010G0BDAAAF
|
Genticin (Ear/Eye) | Gentamicin sulfate | Eye | 1 |
|
Hypromellose 0.32% eye drops preservative free
1108010F0AABYBY
|
Hypromellose | Hypromellose | Eye | 1 |
|
Idebenone 150mg capsules
1108030ABAAABAB
|
Idebenone | Idebenone | Eye | 1 |
|
Isopto Alkaline 1% eye drops
1108010F0BBAAAC
|
Isopto Alkaline | Hypromellose | Eye | 1 |
|
Lumigan 300micrograms/ml eye drops
1106000AFBBAAAA
|
Lumigan | Bimatoprost | Eye | 1 |
|
Mercaptamine 0.55% eye drops preservative free
1108010A0AAAEAE
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 1 |
|
Mercaptamine 3.8mg/ml eye drops
1108010A0AAAFAF
|
Mercaptamine hydrochloride (Eye) | Mercaptamine hydrochloride | Eye | 1 |
|
Natamycin 5% eye drops preservative free
1103010P0AAABAB
|
Natamycin (Eye) | Natamycin | Eye | 1 |
|
Netilmicin 3mg/ml eye drops 0.3ml unit dose
1103010AMAAAAAA
|
Netilmicin | Netilmicin (Eye) | Eye | 1 |
|
Ongavia 2.3mg/0.23ml solution for injection vials
1108020ADBCAAAB
|
Ongavia | Ranibizumab | Eye | 1 |
|
Optrex 13% eye lotion
110402000BBAEA0
|
Proprietary compound preparation BNF 1104020 | Other anti-inflammatory preparations | Eye | 1 |
|
Pilocarpine hydrochloride 0.4% eye drops preservative free
1106000X0AABKBK
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | 1 |
|
Pilocarpine hydrochloride 0.5% eye drops preservative free
1106000X0AABGBG
|
Pilocarpine hydrochloride (Eye) | Pilocarpine hydrochloride | Eye | 1 |
|
Prednisolone sodium phosphate 0.5% eye dps preservative free
1104010S0AAARAR
|
Prednisolone sodium phosphate (Ear/Eye) | Prednisolone sodium phosphate | Eye | 1 |
|
Sodium chloride 0.5% eye drops
1108010K0AAAWAW
|
Sodium chloride (Eye) | Sodium chloride | Eye | 1 |
|
Sodium chloride 0.5% eye drops preservative free
1108010K0AACCCC
|
Sodium chloride (Eye) | Sodium chloride | Eye | 1 |
|
Sodium chloride 2% eye drops
1108010K0AAALAL
|
Sodium chloride (Eye) | Sodium chloride | Eye | 1 |
|
Timolol 0.5% eye drops 0.2ml unit dose preservative free
1106000Z0AAALAL
|
Timolol (Eye) | Timolol | Eye | 1 |
|
Timoptol Unit Dose 0.5% ophthalmic solution 0.2ml unit dose
1106000Z0BBADAL
|
Timoptol | Timolol | Eye | 1 |
|
Acetazolamide 10mg/5ml oral liquid
1106000B0AABDBD
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 110mg/5ml oral liquid
1106000B0AAA6A6
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 120mg/5ml oral liquid
1106000B0AAA5A5
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 145mg/5ml oral liquid
1106000B0AABFBF
|
Acetazolamide | Acetazolamide | Eye | No data available |
|
Acetazolamide 150mg/5ml oral liquid
1106000B0AAA7A7
|
Acetazolamide | Acetazolamide | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.